These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2531910)

  • 1. [Mesoglycan in acute focal cerebral ischemia].
    Cazzato G; Zorzon M; Masé G; Antonutti L; Iona LG
    Riv Neurol; 1989; 59(3):121-6. PubMed ID: 2531910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoglycan in treatment of patients with cerebral ischemia: effects on hemorheologic and hematochemical parameters.
    Vecchio F; Zanchin G; Maggioni F; Santambrogio C; De Zanche L
    Acta Neurol (Napoli); 1993 Dec; 15(6):449-56. PubMed ID: 8160557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of mesoglycan therapy in patients with ischemia of the lower limbs. Preliminary results of a new therapeutic protocol].
    Raso AM; Maggio D; Trogolo M; Rispoli P; Sandrone N; Pezzuto D; Bellan A; Melloni CD
    Minerva Cardioangiol; 1997; 45(7-8):383-92. PubMed ID: 9463174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of mechanical edema: a randomized controlled trial about the effects of mesoglycan.
    Viliani T; Scarselli M; Pieri A; Gatti M; Santini M; Pasquetti P
    Eur J Phys Rehabil Med; 2009 Mar; 45(1):21-9. PubMed ID: 19270639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
    Andreozzi GM
    Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats.
    Schäbitz WR; Schwab S; Spranger M; Hacke W
    J Cereb Blood Flow Metab; 1997 May; 17(5):500-6. PubMed ID: 9183287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG; Gresele P; Ferrari G; Santoro L; Gianese F;
    Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open trial of mesoglycan in the treatment of cerebrovascular ischemic disease.
    Mansi D; Sinisi L; De Michele G; Di Geronimo G; Palma V; Brescia Morra V; Coppola N; Buscaino GA
    Acta Neurol (Napoli); 1988 Apr; 10(2):108-12. PubMed ID: 2969172
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness of mesoglycan topical treatment of leg ulcers in subjects with chronic venous insufficiency].
    La Marca G; Pumilia G; Martino A
    Minerva Cardioangiol; 1999 Sep; 47(9):315-9. PubMed ID: 10630070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical-instrumental evaluation of the effects of mesoglycan sulphate in chronic vascular encephalopathy.
    Orlandi G; Viapiano F; Massetani R; Ferrari M; Murri L
    Acta Neurol (Napoli); 1991 Jun; 13(3):255-60. PubMed ID: 1833956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers.
    Arosio E; Ferrari G; Santoro L; Gianese F; Coccheri S;
    Eur J Vasc Endovasc Surg; 2001 Oct; 22(4):365-72. PubMed ID: 11563899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects on the coagulation-fibrinolysis system of a single oral dose of mesoglycan at the beginning and at the end of a prolonged treatment in man].
    Blardi P; Messa G; Puccetti L; La Placa G; Ghezzi A
    Recenti Prog Med; 1995; 86(7-8):282-9. PubMed ID: 7569284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heparan sulfate in the therapy of postphlebitic syndrome. Evaluation of the efficacy and tolerability as compared to mesoglycan].
    Giorgetti PL; Marenghi MC; Bianciardi P
    Minerva Cardioangiol; 1997 Jun; 45(6):279-84. PubMed ID: 9432569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the arterial input function on the measured perfusion values and infarct volumetric in acute cerebral ischemia evaluated by perfusion computed tomography.
    Bisdas S; Konstantinou GN; Gurung J; Lehnert T; Donnerstag F; Becker H; Vogl TJ; Koh TS
    Invest Radiol; 2007 Mar; 42(3):147-56. PubMed ID: 17287644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized double-blind controlled study of nimodipine in acute cerebral ischemic stroke.
    Nag D; Garg RK; Varma M
    Indian J Physiol Pharmacol; 1998 Oct; 42(4):555-8. PubMed ID: 10874361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of mesoglycan in the prevention of cerebral ischemia].
    Bettini R; Maino C; Gorini M
    Clin Ter; 2003; 154(1):13-6. PubMed ID: 12854278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.